180O IMpassion132 double-blind randomised phase III trial of chemotherapy (CT) ± atezolizumab (atezo) for early-relapsing unresectable locally advanced or metastatic triple-negative breast cancer (aTNBC)

Authors:
  • RDR.A. Dent
    R.A. Dent
  • FAF. André
    F. André
  • AGA. Gonçalves
    A. Gonçalves
  • MJM. Martin Jimenez
    M. Martin Jimenez
  • PSP. Schmid
    P. Schmid
  • FSF. Schütz
    F. Schütz
  • SKS. Kummel
    S. Kummel
  • SSS.M. Swain
    S.M. Swain
  • ABA. Bilici
    A. Bilici
  • DLD. Loirat
    D. Loirat
  • RVR. Villalobos Valencia
    R. Villalobos Valencia
  • SIS-A. Im
    S-A. Im

Abstract
No abstract available